Booth v. Davis

690 F. App'x 571
CourtCourt of Appeals for the Tenth Circuit
DecidedMay 25, 2017
Docket16-3153, 16-3167, 16-3156, 16-3168
StatusUnpublished
Cited by1 cases

This text of 690 F. App'x 571 (Booth v. Davis) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Booth v. Davis, 690 F. App'x 571 (10th Cir. 2017).

Opinion

ORDER AND JUDGMENT *

Carlos F. Lucero, Circuit Judge

In 2002 and 2003, defendant attorney Grant Davis represented several hundred individuals in lawsuits against two pharmaceutical companies. Some of those individuals now claim Davis committed legal malpractice by failing to disclose to them material information pertaining to a settlement agreement with the drug companies. 1 The district court dismissed their legal malpractice claims on the ground that they were time-barred under Kansas’ two-year statute of limitations. Exercising jurisdiction under 28 U.S.C. § 1291, we affirm. 2

I

The malpractice claims in this case arise out of the same underlying facts as the malpractice claims addressed in our prior decision, Wille v. Davis, 650 Fed.Appx. 627 (10th Cir. 2016) (unpublished). In 2002 and 2003, Davis and his law firm represented numerous individuals in lawsuits against pharmacist Robert Courtney, a pharmacy, and two pharmaceutical companies — Eli Lilly & Company and Bristol-Myers Squibb Company — for the alleged dilution of chemotherapy drugs. In late 2002, the drug companies proposed a global settlement agreement intended to resolve all cases pending against them and to set aside money for future cases. The- companies expressly reserved the right to opt out of the agreement if “fewer than all of the Covered Individuals accept[ed]” the proposed settlement. In addition, the settlement was contingent upon Georgia Hayes, who had filed the lead case against the drug companies, “complying with all the terms and conditions of’ a separate agreement, under which the companies would pay her $2.9 million in exchange for the dismissal of her claims.

Davis informed plaintiffs of the proposal and provided them with a “Disclosure of Global Settlement.” That disclosure stated that Davis’ law firm represented most of the individuals who had filed lawsuits against the drug companies, that Eli Lilly and Bristol-Myers Squibb had made a joint settlement offer to resolve all of those lawsuits, and that the companies had each offered Hayes a separate settlement of $1.45 million. By signing the disclosure, plaintiffs represented that they had reviewed the terms of the settlement agreement and understood that their right to receive funds would be determined by a Special Master. They also signed a “Re *573 lease and Settlement Agreement” acknowledging “that they underst[ood] the process by which settlement amounts [would] be determined.”

On May 20, 2003, the Special Masters determined plaintiffs’ settlement awards. Connie Booth and Kimberly Carrel signed a Settlement Sheet acknowledging receipt of their awards on June 24, 2003; Prudence Kirkegaard and Dorothy Schmitz, on July 10, 2003. All awards were substantially lower than what Hayes had received from the drug companies.

In April 2004, another family who had participated in the global settlement — the Tilzers — filed a legal malpractice suit against Davis in Kansas state court. See Tilzer v. Davis, Bethune & Jones, L.L.C., 288 Kan. 477, 204 P.3d 617, 621 (2009). On appeal, the Kansas Supreme Court held that the global settlement constituted an “aggregate settlement” under Missouri Rule of Professional Conduct 44.8(g), requiring Davis to disclose to his clients “the existence and nature of all of the claims and of the participation of each person in the settlement” in order to obtain informed consent. Tilzer, 204 P.3d at 627-28. It further concluded that the settlement ran “afoul of the ABA guidelines” because damage awards were not negotiated on behalf of individual plaintiffs and the structure of the settlement made it impossible for Davis to make the required disclosures. Id. at 629. The Kansas Supreme Court decision was filed on April 3, 2009. However, the proceedings were subject to a protective order, which prevented the Tilzers’ attorney from contacting Davis’ other clients, including plaintiffs, until December 2009. The Booth and Schmitz families learned of the Tilzer opinion in December 2009; Carrel and Kirkegaard, in June 2010.

On February 3, 2010, nearly seven years after the global settlement with the drug companies, the Booths and the Schmitz’s filed lawsuits against Davis, alleging legal malpractice based on his failure to disclose material information pertaining to the settlement agreement, including the existence of actual and potential conflicts of interest. Carrel and Kirkegaard filed similar actions on September 29, 2010. The district court granted summary judgment in favor of Davis in all four cases, concluding that plaintiffs’ claims were time-barred under Kansas’ two-year statute of limitations. Plaintiffs timely appealed.

II

We review a grant of summary judgment de novo, applying the same standard as the district court. Duvall v. Georgia-Pacific Consumer Prods., L.P., 607 F.3d 1256, 1259 (10th Cir. 2010). Summary judgment is appropriate if “there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed. R. Civ.P. 56(a).

The parties-agree that plaintiffs’ legal malpractice claims are governed by Kan. Stat. § 60-513(a)(4), which prescribes a two-year limitations period for tort actions. Under Kansas law, a claim accrues when “the act giving rise to the cause of action first causes substantial injury, or, if the fact of injury is not reasonably ascertainable until some time after the initial act,” when “the fact of injury becomes reasonably ascertainable to the injured party.” § 60-513(b). This latter rule “postpones the running of the limitations period until the time the plaintiff is able to determine that her injury may be caused by some act of the defendant.” Benne v. Int’l Bus. Mach. Corp., 87 F.3d 419, 427 (10th Cir. 1996); see also Dearborn Animal Clinic, P.A. v. Wilson, 248 Kan. 257, 806 P.2d 997, 1006 (1991) (stating that limitations period did not begin to run until it was “reasonably ascertainable that the injury was caused by the attorney’s malpractice”). *574 “Reasonably ascertainable does not mean actual knowledge.” Davidson v. Denning, 259 Kan. 659, 914 P.2d 936, 948 (1996) (quotations omitted). The standard “carries with it an obligation to investigate available factual sources,” Bi-State Dev. Co. v. Shafer, Kline & Warren, Inc., 26 Kan.App.2d 515, 990 P.2d 159, 162 (1999), and is met if “the plaintiff knew or could reasonably have been expected to know of the alleged negligence,” Knight v. Myers, 12 Kan.App.2d 469, 748 P.2d 896, 901 (1988).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Mobley v. Kerns
D. Kansas, 2020

Cite This Page — Counsel Stack

Bluebook (online)
690 F. App'x 571, Counsel Stack Legal Research, https://law.counselstack.com/opinion/booth-v-davis-ca10-2017.